As parties to the United States-Mexico-Canada Agreement (USMCA), Canada and Mexico have agreed to adopt important intellectual property protections for biologic medicines.
The Innovate4Health project tells the exciting story of people who are solving the world’s biggest health challenges through innovation.
Taiwan’s downward revision of its growth and export forecasts last month confirms the need to diversify from its main business of exporting manufactured commodities.
Countries that want to build an innovation driven knowledge-economy should embrace patent linkage, writes Jack Ellis
Mr Odon’s imagination allowed him to look at an old problem in new way. But the long road to commercialisation has required cooperation, investment and perspiration — and that is where intellectual property rights have been key.
To ensure modern trade and investment can continue on non-discriminatory terms for everyone, the WTO should put Intellectual property first.
Section 3(d) of India’s patent law may be putting India at a competitive disadvantage. The data presented in this research note shows it is preventing Indian generic pharmaceutical companies from developing new formulations, compositions, and combinations of existing medicines, which they instead undertake and commercialise abroad.